This inventor holds 32 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Electrophoresis Technology. Top assignees: Hitachi, Ltd., Chugai Seiyaku Kabushiki Kaisha, Research Association for Biotechnology. Active years: 1986-2014.
Location History:
- Higashiyamatoshi, JP (2004)
- Tokyo, JP (1986 - 2012)
- Higashiyamato, JP (1990 - 2014)
Company Filing History:
24 out of 42,726 
3 out of 985 
3 out of 4 
Years Active: 1986-2014
Areas of Expertise:
Title: The Innovative Contributions of Keiichi Nagai
Introduction
Keiichi Nagai, based in Higashiyamato, Japan, is a prolific inventor recognized for his substantial contributions to the field of biotechnology. With a remarkable portfolio of 32 patents, he has made significant advancements in cancer diagnostics and the study of smooth muscle cell differentiation.
Latest Patents
Nagai's recent innovations include a "Method and Kit for Detection of Microsatellite Instability-Positive Cell," which provides a robust technique for identifying abnormal cells via gene expression analysis. This method focuses on measuring the expression levels of transcripts from the human MLH1 gene and comparing them to detect cells with microsatellite instability, aiding in cancer diagnosis. Another noteworthy patent is for an "Antibody Directed to Protein Involved in Maintaining Differentiation of Smooth Muscle Cells." This invention is centered around a cDNA fragment that plays a crucial role in the maintenance of smooth muscle cell differentiation, offering potential pathways for developing drugs to treat various diseases linked with abnormal differentiation.
Career Highlights
Throughout his career, Keiichi Nagai has collaborated with prestigious organizations such as Hitachi, Ltd. and the Research Association for Biotechnology. His expertise has propelled him to the forefront of research in biotechnology, resulting in groundbreaking inventions that hold the promise of improving health outcomes.
Collaborations
During his tenure in the industry, Nagai has worked alongside accomplished colleagues, including Hideki Kambara and Takao Isogai. These collaborations have contributed to his innovative patents and have fostered an environment of shared knowledge and discovery within the field.
Conclusion
Keiichi Nagai is a remarkable inventor with a strong legacy in the biotechnology sector. His 32 patents illustrate his commitment to advancing science, particularly in cancer diagnostics and cellular biology. As he continues to innovate, his work is poised to have a lasting impact on healthcare and our understanding of cellular processes.